Hyperglycemia After Dolutegravir-Based Antiretroviral Therapy

BACKGROUND: Antiretroviral therapies prolong life expectancy and improve the quality of life of HIV-infected patients. Despite the documented benefits of antiretroviral drugs, its use is not without side effects. Here, we report cases of new onset diabetes mellitus after taking a dolutegravir (DTG)-...

Descripción completa

Detalles Bibliográficos
Autores principales: Hailu, Workagegnehu, Tesfaye, Tsebaot, Tadesse, Abilo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326784/
https://www.ncbi.nlm.nih.gov/pubmed/34349567
http://dx.doi.org/10.2147/IMCRJ.S323233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326784/
https://www.ncbi.nlm.nih.gov/pubmed/34349567
http://dx.doi.org/10.2147/IMCRJ.S323233

Ejemplares similares